I'm going to defer to Ms. Gruenwoldt, who has been much more involved on that.
Very quickly, there aren't a lot of pediatric-friendly formulations. A lot of what we learn and apply to children's care comes from research in adults. There are a lot of medications that are simply not on public formularies. There are a number of strategies for which a pharmacare strategy will be important.